- £1.86bn
- £4.23bn
- $1.42bn
- 53
- 75
- 40
- 57
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 75.7 | 28 | 497 | 737 | 1,420 |
Cost of Revenue | |||||
Gross Profit | 10.2 | -20.4 | 152 | 378 | 660 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 170 | 153 | 465 | 505 | 821 |
Operating Profit | -93.9 | -125 | 32.1 | 232 | 598 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -104 | -114 | -90.7 | 107 | 344 |
Provision for Income Taxes | |||||
Net Income After Taxes | -83.8 | -92.9 | -96.2 | 17.3 | 185 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -83.3 | -91.4 | -96 | 17.3 | 185 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -83.3 | -91.4 | -96 | 17.3 | 185 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.151 | -0.197 | -0.24 | 0.456 | 1.05 |
Dividends per Share |